Fludarabine metabolite level on day zero does not affect outcomes of hematopoietic cell transplantation in patients with normal renal function.

Griffiths, C D; Ng, E S M; Kangarloo, S B; Williamson, T S; Chaudhry, M A; Booker, R; Duggan, P; Yue, P; Savoie, L; Brown, C; Cox-Kennett, N; Russell, J A; Daly, A; Storek, J

Griffiths, C D; Ng, E S M; Kangarloo, S B; Williamson, T S; Chaudhry, M A; Booker, R; Duggan, P; Yue, P; Savoie, L; Brown, C; Cox-Kennett, N; Russell, J A; Daly, A; Storek, J.

Afiliación

Griffiths CD; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Ng ES; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Kangarloo SB; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Williamson TS; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Chaudhry MA; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Booker R; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Duggan P; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Yue P; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Savoie L; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Brown C; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Cox-Kennett N; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Russell JA; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Daly A; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.
Storek J; Department of Internal Medicine, University of Calgary & Alberta Health Services, Calgary, Alberta, Canada.

Bone Marrow Transplant ; 49(4): 589-91, 2014 Apr.

Article en En | MEDLINE | ID: mdl-24464143

Asunto(s)

Trasplante de Células Madre Hematopoyéticas/métodos; Acondicionamiento Pretrasplante/métodos; Vidarabina/análogos & derivados; Humanos; Riñón/metabolismo; Análisis Multivariante; Resultado del Tratamiento; Vidarabina/sangre; Vidarabina/farmacocinética

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vidarabina / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2014 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google